Two examples of CT myocardial perfusion (CTP) imaging assessment software. Canon is on the left and GE Healthcare is on the right. Both of these technologies have been around for a few years, but there have been an increasing amount of clinical data from studies showing the accuracy of the technology compared to nuclear imaging, the current stand of care for myocardial perfusion imaging, and cardiac MRI.
Feature | CT Angiography (CTA) | Dave Fornell, Editor
New Technologies Take Cardiac CT to the Next Level

Here is an overview of a few of the biggest technology advances in cardiovascular computed tomography (CT). These are ...

Home June 08, 2020
Home
News | Heart Valve Technology
Edwards Sapien 3 Transcatheter Heart Valve Receives Approval In China

June 8, 2020 — Edwards Lifesciences Corp. announced Chinese regulatory approval for the Edwards Sapien 3 transcatheter ...

Home June 08, 2020
Home
BD (Becton, Dickinson and Company, and Bard) launched the Halo One Thin-Walled Guiding Sheath, designed to perform as both a guiding sheath and an introducer sheath, for use in peripheral arterial and venous procedures requiring percutaneous introduction of intravascular devices.
News | Vascular Access
BD Launches of Halo One Thin-Walled Guiding Sheath

June 8, 2020 – BD (Becton, Dickinson and Company) launched the Halo One Thin-Walled Guiding Sheath, designed to perform ...

Home June 08, 2020
Home
Russian interventional cardiologist Alexey Pankov in full personal protective equipment (PPE) for a cath lab procedure in Moscow during the COVID-19 era. Right, an image of the COVID-19 virus from the National Institutes of Health (NIH).
Feature | Coronavirus (COVID-19) | Dave Fornell, Editor
The Cardiovascular Impact of COVID-19

It was originally thought novel coronavirus (COVID-19, SARS-CoV-2) was primarily a respiratory disorder, but as larger ...

Home June 05, 2020
Home
Abiomed announced the U.S. Food and Drug Administration (FDA) has approved the company's investigational device exemption (IDE) application to start an early feasibility study with a first-in-human trial of the 9 French (Fr) Impella ECP heart pump. Impella ECP, which stands for "expandable cardiac power," will be studied in high-risk percutaneous coronary intervention (PCI) patients.
News | Hemodynamic Support Devices
FDA Approves First-in-Human Trial of Impella ECP World’s Smallest Heart Pump

June 5, 2020 — Abiomed announced the U.S. Food and Drug Administration (FDA) has approved the company's investigational ...

Home June 05, 2020
Home
Videos | Hemodynamic Support Devices
VIDEO: Demonstration of Abiomed Impella ECP 9 French Transcatheter Ventricular Assist Device

This is a quick animation demonstrating how the new 9 French Abiomed Impella ECP expands to approximately 18 French and ...

Home June 05, 2020
Home
A Philips Healthcare transesophageal echocardiography (TEE) system in use in a hybrid OR.
News | Cardiovascular Ultrasound
New Guideline Outlines Use of Transesophageal Echo to Assist Surgical Decision-making

June 4, 2020 — Intra-operative transesophageal echocardiography (TEE) is a versatile diagnostic and monitoring tool used ...

Home June 04, 2020
Home
Transit Scientific announced the U.S. Food and Drug Administration (FDA) cleared the XO Score Percutaneous Transluminal Angioplasty (PTA) Scoring Sheath platform for use in iliac, ilio-femoral, popliteal, infra-popliteal and renal arterial plus synthetic and/or native arteriovenous hemodialysis fistula. This is a new type of scoring balloon technology.
News | Balloon Catheter
FDA Clears Scoring Sheath That Fits Over Standard Angioplasty Balloons

June 4, 2020 — Transit Scientific announced the U.S. Food and Drug Administration (FDA) cleared the XO Score ...

Home June 04, 2020
Home
All coronavirus content continued as the most popular content in May 2020. Two of the major topics included an article on the new Kawasaki-like inflammatory disease that affects children with COVID-19 and articles and videos on the cardiovascular effects of hydroxychloroquine in treating or preventing COVID. #COVID19 #SARScov2
Feature | Dave Fornell, Editor
Most Popular Cardiology Technology Content in May 2020

June 4, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

Home June 04, 2020
Home
Societies Issue Guide to Safely Resume Cardiovascular Procedures, Diagnostic Tests. #COVID19 #SARScov2
Feature | Cardiovascular Business
Societies Issue Guide to Safely Resume Cardiovascular Procedures and Tests

The American College of Cardiology (ACC) together with other North American cardiovascular societies issued a framework ...

Home June 03, 2020
Home
This is Figure 2 from the article in Radiology: Acute encephalopathy. A 60 year-old-man without history of seizures presenting with convulsion. (A-B) Multifocal areas of FLAIR hyperintensity in the right cerebellum (arrows in A), left anterior cingular cortex and superior frontal gyrus (arrows in B). (C-D) Restricted diffusion in the left anterior cingulate cortex, superior frontal and middle temporal gyrus (arrows in D) and right cerebellum (arrows in E), consistent with cerebellar diaschisis. #COVID19
Feature | Coronavirus (COVID-19)
How COVID-19 Effects the Brain in Neuroimaging

June 2, 2020 — Four recent radiology studies, from New York, Italy, Iran and China, show how COVID-19 (SARS-CoV-2) ...

Home June 02, 2020
Home
he U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the Abiomed Impella RP catheter-based heart pump to include patients suffering from COVID-19 related right heart failure or decompensation, including pulmonary embolism (PE).  #COVID19 #SARScov2
Feature | Coronavirus (COVID-19)
Impella RP Granted FDA Emergency Use Authorization for COVID-19 Patients With Right Heart Failure

June 1, 2020 — The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the ...

Home June 01, 2020
Home
Nuclear Cardiology Optimistic About Return to Pre-COVID-19 Exam Levels. An American Society of Nuclear Cardiology (ASNC) member survey are confident nuclear cardiology volumes will return to pre-pandemic levels. #COVID19 #SARScov2
News | Coronavirus (COVID-19)
Nuclear Cardiology Optimistic About Return to Pre-COVID-19 Exam Levels

June 1, 2020 — While acknowledging the challenges their specialty is facing, more than two-thirds of respondents to an ...

Home June 01, 2020
Home
New Data Confirms Majority of Americans Avoiding Treatment for Heart Attack and Stroke Due to COVID-19. Physio-Control LifePak defibrillator monitor.
Feature | Coronavirus (COVID-19)
New Data Confirms Majority of Americans Avoiding Treatment for Heart Attack and Stroke Due to COVID-19

May 29, 2020 — As states begin to re-open as the number of COVID-19 patients declines, 40 percent of Americans still ...

Home May 29, 2020
Home
Videos | Coronavirus (COVID-19)
VIDEO: Creating a Home COVID-19 Decontamination Area for the Clinician

Jay Mohan, D.O., RPVI, interventional cardiology fellow at William Beaumont Hospital, Royal Oak, Michigan, created this ...

Home May 29, 2020
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now